In vivo pharmacokinetic and brain binding characteristics of (+)-[(11)C]A-69024, a high-affinity-D1-selective dopamine receptor antagonist, were assessed with micro-PET and beta-microprobes in the rat and PET in the baboon. The biodistribution of (+)-[(11)C]A-69024 in rats and baboons showed a rapid
In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine
✍ Scribed by Jean N. DaSilva; Dr. Michael R. Kilbourn; Edward F. Domino
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 792 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0887-4476
No coin nor oath required. For personal study only.
✦ Synopsis
The first successful in vivo imaging of monoamine vesicular transporters in the living primate brain is described, using [llcltetrabenazine (["ClTBZ) and Positron Emission Tomography (PET). Radioligand uptake into brain is rapid, and at short time periods (10-30 minutes) the higher uptake and retention of the radiotracer in the more densely dopaminergic innervated striaturn is clearly visualized. Specific binding in striatum can be entirely blocked with co-administration of a pharmacological dose (1 m a g i.v.1 of tetrabenazine. In a unilaterally MPTP-lesioned monkey, specific binding of radioligand was absent in the striatum on the lesioned side, with no effect on radiotracer distribution in the cortex, cerebellum or contralateral striatum. PET imaging with [llC]TBZ provides a new approach to the in vivo study of monoaminergic neurons and their loss in neurodegenerative diseases.
📜 SIMILAR VOLUMES
## Abstract Based upon data obtained with our arterio‐venous technique for the determination of cerebral metabolism in humans in vivo we have proposed a method for the determination of cerebral regional intermediary glucose metabolism in humans in vivo using specifically labeled ^11^C‐glucose and p